Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer
Clinical trial NCT04742075 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04742075
- Sponsor
- Nordic Society of Gynaecological Oncology - Clinical Trials Unit
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2026-05-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.